文献速递妇科

病理I期上皮性卵巢癌腹腔镜与开腹手术后的复发与生存比较:倾向匹配队列的回顾性分析

Comparison of Recurrence and Survival Between Patients With Pathological Stage I Epithelial Ovarian Cancer After Laparoscopic or Laparotomic Surgery: Retrospective Analysis of a Propensity-Matched Cohort.
PubMed 文献 · J Minim Invasive Gynecol · 2024-07-14

该回顾性队列研究比较了FIGO I期上皮性卵巢癌患者接受腹腔镜或开腹分期手术的肿瘤学结局。倾向匹配后每组82例,5年无进展生存率腹腔镜组87.1% vs 开腹组90.9%(p=0.524),5年总生存率93.9% vs 94.7%(p=0.900),复发率均为9-11%,两组相似。作者认为腹腔镜可能是有益患者的有效替代方案。

要点

  • 倾向匹配后腹腔镜组与开腹组5年无进展生存率分别为87.1%和90.9%,无显著差异。
  • 匹配后5年总生存率腹腔镜组93.9% vs 开腹组94.7%,无显著差异。
  • 两组复发率均为9-11%,中位随访54.9个月。

核心结论

  • 腹腔镜与开腹手术治疗I期上皮性卵巢癌的复发率和生存率可能相似,腹腔镜出血少、恢复快,可能是合适患者的有效替代方案。

研究设计与样本

  • 回顾性队列研究,纳入2013年1月1日至2019年12月31日于四川大学华西第二医院就诊的85例FIGO I期上皮性卵巢癌腹腔镜分期手术患者和206例开腹分期手术患者。

主要发现

  • 倾向匹配前,开腹组术前CA125升高比例高于腹腔镜组(48.5% vs 35.3%,p=0.045),肿瘤>15 cm比例也高于腹腔镜组(27.2% vs 5.9%,p<0.001)。
  • 多因素分析显示较高的体重指数与更好的总生存相关(校正HR 0.83,95%CI 0.70-0.99,p=0.043)。
  • 倾向匹配后每组82例,5年无进展生存率腹腔镜组87.1%(95%CI 79.3-95.7%)vs 开腹组90.9%(95%CI 84.7-97.6%),p=0.524。
  • 倾向匹配后5年总生存率腹腔镜组93.9%(95%CI 88.0-100.0%)vs 开腹组94.7%(95%CI 89.8-99.9%),p=0.900。
  • 无论是否匹配,两组随访期间复发率均为9-11%,中位随访54.9个月。

临床怎么用

  • 作者认为,腹腔镜出血少、恢复快,可能是有益患者的腹腔镜手术安全有效的开腹替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare oncologic outcomes after laparoscopic or laparotomic surgery to treat epithelial ovarian carcinoma in FIGO Stage I. DESIGN: Retrospective cohort study. SETTING: Gynecological cancer ward in a tertiary hospital. PARTICIPANTS: A total of 85 patients with FIGO Stage I epithelial ovarian carcinoma who underwent laparoscopic staging surgery and 206 who underwent laparotomic staging surgery at West China Second Hospital, Sichuan University (Chengdu, China) between January 1, 2013 and December 31, 2019. INTERVENTIONS: Laparoscopic surgery or laparotomic staging surgery. RESULTS: Before propensity score-based matching, the laparotomy group showed higher prevalence of preoperative elevated CA125 level (48.5% vs 35.3%, p = .045) and tumors >15 cm (27.2% vs 5.9%, p <.001). Multivariate analysis associated higher body mass index with better overall survival (adjusted HR 0.83, 95% CI 0.70-0.99, p = .043). Among propensity score-matched patients (82 per group) who were matched to each other according to propensity scoring based on age, body mass index, CA125 level, largest tumor diameter, FIGO stage, history of abdominal surgery, and American Society of Anesthesiologists grade, the rate of progression-free survival at 5 years was similar between the laparoscopy group (87.1%, 95% CI 79.3-95.7%) and the laparotomy group (90.9%, 95% CI 84.7-97.6%, p = .524), as was the rate of overall survival at 5 years (93.9%, 95% CI 88.0-100.0% vs 94.7%, 95% CI 89.8-99.9%, p = .900). Regardless of whether patients were matched, the two groups showed similar rates of recurrence of 9-11% during follow-up lasting a median of 54.9 months. CONCLUSIONS: Rates of recurrence and survival may be similar between laparoscopy or laparotomy to treat Stage I epithelial ovarian cancer. Since laparoscopy is associated with less bleeding and faster recovery, it may be a safe, effective alternative to laparotomy for appropriate patients.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Cao SY, Fan Y, Zhao CY, et al. Comparison of Recurrence and Survival Between Patients With Pathological Stage I Epithelial Ovarian Cancer After Laparoscopic or Laparotomic Surgery: Retrospective Analysis of a Propensity-Matched Cohort. J Minim Invasive Gynecol. 2024. PMID: 39004184. doi:10.1016/j.jmig.2024.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。